Metraipolis › archive › dc_ef7397aa0d4c

Norrin in cancer: from a promising prognostic biomarker to a novel therapeutic target — Europe PMC PMID:41357583

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41357583
DOI
10.3389/fonc.2025.1692715
License (as archived)
solo-consultazione
Archived
2026-11-08T09:07:26.487Z
SHA-256 of the archived text
5b3172dc25edc50d20f1c36c6d4a412a92d3dfa18233a55f926ab4678d79543c
Stable URL of this page
https://metraipolis.com/documento/dc_ef7397aa0d4c

How to cite

Norrin in cancer: from a promising prognostic biomarker to a novel therapeutic target — Europe PMC PMID:41357583 — Europe PMC (en), https://europepmc.org/article/MED/41357583 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef7397aa0d4c (Metraipolis archive dc_ef7397aa0d4c, sha256 5b3172dc25edc50d20f1c36c6d4a412a92d3dfa18233a55f926ab4678d79543c)
BibTeX
@misc{dcef7397aa0d4c,
  title = {Norrin in cancer: from a promising prognostic biomarker to a novel therapeutic target — Europe PMC PMID:41357583},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41357583},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef7397aa0d4c; sha256 5b3172dc25edc50d20f1c36c6d4a412a92d3dfa18233a55f926ab4678d79543c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41357583. Agents can read the archived copy with the MCP tool read_document.